Ehud Isacoff, DOE/Lawrence Berkeley National Laboratory (IMAGE)

DOE/Lawrence Berkeley National Laboratory

Ehud Isacoff, DOE/Lawrence Berkeley National Laboratory

Caption

Guillaume Sandoz (seated) and Ehud Isacoff developed a unique fluorescent assay technique that enabled them to the TREK1, a protein that could be a target for antidepressants.

Credit

Photo by Roy Kaltschmidt, Berkeley Lab Public Affairs

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.